14 Stocks Jim Cramer Recently Shared Insights On
“You can make a lot of money speculating. But remember, you haven't really made any money until you sell something.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.25 | 23,107 | $1,091,766.47 | 63,222 | 2025-06-23 | Filing | |
| $59.75 | 17,102 | $1,021,844.50 | 278,654 | 2025-06-17 | Filing | |
| $59.45 | 49,165 | $2,922,706.84 | 95,105 | 2025-06-17 | Filing | |
| $58.50 | 15,945 | $932,835.12 | 144,270 | 2025-06-17 | Filing | |
| $56.92 | 17,710 | $1,008,012.47 | 160,215 | 2025-06-16 | Filing |
Institutional Investors' Holdings
News See All
Hims & Hers (HIMS) Slashes 34.6% as Novo Nordisk Terminates Partnership
In a statement, Novo Nordisk said it ended its collaboration with Hims & Hers Health, Inc.
Hims & Hers Health (HIMS) Surged on Weight Loss Offering Advertisement Campaign
Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here's Why Hims & Hers Health (HIMS) Soared in Q1
Renaissance Investment Management, an investment management company, released its Q1 2025 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on M. V. Cunha’s Substack. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Needham Lifts PT on Hims & Hers Health (HIMS) Stock, Maintains Buy Rating
On June 4, Needham upped the price objective on Hims & Hers Health, Inc.
Citi Keeps Hims & Hers (HIMS) Price Target, Maintains Sell Rating
Citi is holding firm on its Sell rating for Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth Strategy
The company stated that the deal is expected to be finalized by mid-year.
Why Hims & Hers Health, Inc. (HIMS) Surged On Friday
We recently published a list of Investors Rushed Into These 10 Stocks Today.
Why Hims & Hers Health Inc. (HIMS) Went Down On Tuesday
We recently published a list of 10 Stocks Got Wiped Out. Are You Holding Any? In this article, we are going to take a look at where Hims & Hers Health Inc.